Contract Research

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).

Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

002500: Challenges and Solutions for Budget Impact Analysis of Gene Therapies

Nadine Henderson;Paul Oyalo;Ellie Tunnicliffe;Hania El Banhawi;SooChin Yen;Grace Hampson

002499: Establishing the Economic Value of Carbon-Minimal Inhalers

Sukanya Subramaniyan;Grace Hampson

002498: The Importance of Diversity of Supply in Rare Diseases Markets

Matthew Napier;Brittany Darrow;Matthias Hofer;Mikel Berdud;Amanda Cole

002496: Employer Costs from Respiratory Infections

Helen Hayes;Brittany Darrow;Lotte Steuten;Graham Cookson;Amanda Cole

002495: Understanding societal preferences for priority by disease severity in England & Wales

Helen Hayes;Priscila Radu;David Mott;Chris Skedgel

002494: A Spotlight on Haemophilia Therapies

Nadine Henderson;Matthias Hofer;George Bray;Dimitrios Kourouklis;Mikel Berdud;Grace Hampson

002493: The Cost of Drug Shortages

Matthew Napier;Mikel Berdud;Amanda Cole

002492: Unlocking the Value of Combination Therapies

George Bray;Lotte Steuten;Gayathri Kumar

002491: Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding

Sian Hodgson;Helen Hayes;Patricia Cubi-Molla;Martina Garau

002490: A Framework for Value-aligned Pricing of Combination Therapies

Matthew Napier;Chris Sampson;Amanda Cole;Martina Garau

002489: How Have HTA Agencies Evolved Their Methods Over Time?

Priscila Radu;Gayathri Kumar;Patricia Cubi-Molla;Martina Garau;Eleanor Bell;Jia Pan;Ramiro Gilardino ;Julie Van Bavel;Agnes Brandtmüller;Katherine Nelson;Melinda Goodall

002488: Socio-Economic Value of Adult Immunisation Programmes

Hania El Banhawi;Sulayman Chowdhury;Margherita Neri;Priscila Radu;Sian Hodgson;Eleanor Bell;Simon Brassel;Lotte Steuten

002487: Incorporating the Patient Voice in Health Technology Assessment

Gayathri Kumar;George Bray;Jia Pan;Chris Skedgel;Kyle Dunton;Francisco Fonseca Santos;Paul Genin;Gunnar Schroefel

002486: Developing a Conceptual Framework of Healthcare System Pressure

Simon Brassel;Margherita Neri;Lotte Steuten;Hannah Schirrmacher;Fernando Albuquerque de Almeida;Apostolos Charos;Katharina Schley;Kimberly Shea

002485: The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?

Gayathri Kumar;Matthew Napier;Margherita Neri;Martina Garau

002483: The Dynamics of Drug Shortages

Matthew Napier;Dimitrios Kourouklis;Amanda Cole;Graham Cookson

002480: Capturing the Broader Value of Antibiotics

Simon Brassel;Isobel Firth;Sulayman Chowdhury;Grace Hampson;Lotte Steuten

002479: Innovation for Health System Efficiency and Improvement

Margherita Neri;Matthias Hofer;Fred McElwee;Jia Pan;Graham Cookson

002478: Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

Matthias Hofer;Grace Hampson

002477: Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Matthias Hofer;Grace Hampson

002474: Supporting the Era of Green Pharmaceuticals in the UK

Jake Hitch;Nadine Henderson;Graham Cookson;Isobel Firth

002473: Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

Adrian Towse;Lotte Steuten

002471: Navigating the Landscape of Digital Health - United Kingdom

Simon Brassel;Priscila Radu;Eleanor Bell;Martina Garau

002470: Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

Sian Hodgson;Amanda Cole;Raoh-Fang Pwu;Jason Chia-Hsun Hsieh

002469: A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Isobel Firth;Jia Pan;Adrian Towse;Lotte Steuten

002468: The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

Chris Sampson;Edward Oliver;Priscila Radu;Tanja Podkonjak;Lotte Steuten

002467: Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

Sian Hodgson;Dimitrios Kourouklis;Phill O’Neill;Martina Garau

002466: The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

Nadine Henderson;Chris Skedgel;Claud Theakston

002464: NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

Nadine Henderson;Simon Brassel;Phill O’Neill;Rachel Allen;Jonathan Cooke;Martina Garau

002463: Are Recommendations for HTA of Gene Therapies Being Achieved?

Sian Hodgson;Nadine Henderson;Matthew Napier;Amanda Cole;Grace Hampson

002462: Delivering the Triple Win: A Value-Based Approach to Pricing

Eleanor Bell;Mikel Berdud;Graham Cookson;Sian Hodgson

002461: Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Simon Brassel;Isobel Firth;Edward Oliver;Grace Hampson;Adrian Towse;Lotte Steuten

002448: Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Sian Hodgson;Nadine Henderson;Adrian Towse;Amanda Cole

002394: Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Graham Cookson;Jake Hitch

002386: The Value of Vaccines in Maintaining Health System Capacity in England

Simon Brassel;Margherita Neri;Lotte Steuten

002377: A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases

Maria Errea;Nadine Henderson;Chris Skedgel;Mireia Jofre-Bonet

002370: The Lower Drug Costs Now Act and Pharmaceutical Innovation

Lou Garrison;Jake Hitch;Grace Hampson;Mireia Jofre-Bonet;Martina Garau;Graham Cookson

002359: Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Marina Rodes Sanchez;Boris Rachev;Julia Spencer;Isha Sharma;Anupama Tantri;Rachel Mitrovich;Adrian Towse;Lotte Steuten

002344: Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective

Mikel Berdud;Mireia Jofre-Bonet;Adrian Towse

002338: The Promise of Gene Therapies: Are We Ready?

Office of Health Economics

002290: Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies

Nadine Henderson;Lotte Steuten

002284: A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold

Mikel Berdud;Jimena Ferraro;Adrian Towse

002283: The Broader Value of Vaccines: The Return on Investment From a Governmental Perspective

Simon Brassel;Lotte Steuten

002282: Realising the Broader Value of Vaccines in the UK

Simon Brassel;Margherita Neri;Phill O’Neill;Lotte Steuten

002280: NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?

Mehmet Bulut;Phill O’Neill;Amanda Cole

002277: Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies

Simon Brassel;Graham Cookson

002271: International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making

Kyann Zhang;Martina Garau

002268: Opportunities to Increase Efficiency in Healthcare

Maria Errea;Chris Skedgel;Bernarda Zamora;Grace Hampson;Graham Cookson;Maria Errea;Rikard Althin;Thomas Hofmarcher;Peter Lindgren

002249: Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?

Karla Hernandez-Villafuerte;Koonal Shah;Mike Herdman;Paula Lorgelly

002247: Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?

Patricia Cubi-Molla;Maria Errea;Kyann Zhang;Martina Garau